Mayo Clinic Laboratories in Rochester, Minn., today will begin testing for monkeypox, the Centers for Disease Control and Prevention announced. Health care providers can order the test from Mayo Clinic Laboratories just as they would other tests, with results reported to jurisdictions as outlined in CDC’s reporting guidance. The laboratory will use CDC’s orthopoxvirus test and anticipates it can handle up to 10,000 tests per week.

“This will not only increase testing capacity but also make it more convenient for providers and patients to access tests by using existing provider-to-laboratory networks,” said CDC Director Rochelle Walensky, M.D.

LabCorp began using the CDC test last week and three other commercial laboratories are expected to soon, joining CDC’s Laboratory Response Network in performing the monkeypox test. CDC has reported over 860 U.S. monkeypox cases since May.
 

Related News Articles

Headline
The Food and Drug Administration yesterday issued an emergency use authorization allowing health care providers to administer the JYNNEOS vaccine intradermally…
Headline
Health and Human Services Secretary Xavier Becerra today took action that will allow the Food and Drug Administration Commissioner to grant emergency use…
Headline
As the number of U.S. monkeypox cases continues to grow, Health and Human Services Secretary Xavier Becerra today declared the outbreak a public health…
Headline
The Department of Health and Human Services has secured an additional 786,000 doses of JYNNEOS monkeypox vaccine, which officials said states can begin…
Headline
The Centers for Disease Control and Prevention today reported over 1,400 U.S. monkeypox cases and no deaths since the outbreak began in May. Federal officials…
Headline
The Centers for Disease Control and Prevention June 30 released guidance for all laboratories that perform diagnostics testing for monkeypox. The guidance…